A Parliamentary panel has recommended major changes to how traditional medicine drugs are regulated in India, calling for the creation of a single, independent authority to oversee the Ayush sector regulation.
A pioneering public health approach developed in West Bengal to combat Type 1 diabetes (T1D) is set to gain international traction, with several Southeast Asian countries expressing interest in adopting the model, marking a significa...
India has stepped up action against GLP-1 drug misuse as cheaper generic versions flood the market, raising safety concerns. The Drugs Controller General of India has launched nationwide audits and inspections to curb GLP-1 drug misuse and...
Jharkhand’s Health Minister Irfan Ansari on Wednesday announced the Jharkhand health cottages plan, a major step to boost rural healthcare by setting up health cottages in every panchayat.
Alkem Laboratories Ltd. today announced the launch of A to Z Daily, an everyday multivitamin supplement for adults, for providing holistic nutritional support to the body and mind.
Aurobindo Pharma has secured a key Aurobindo Pharma USFDA approval to manufacture and market Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the U.S.
Merck is moving to strengthen its global production network, placing boost filtration supply at the center of its latest Bengaluru facility.
Kiran Mazumdar-Shaw has raised concerns over India’s listing rules, saying the current system fails biotech startups in India. She urged to rethink IPO norms for Biotech startups.
Biocon Biologics, a subsidiary of Biocon, has launched its denosumab biosimilars—Bosaya and Aukelso—in the US market, marking an important milestone in the company’s global expansion journey.
Mumbai-based drugmaker Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its generic Dapagliflozin tablets, strengthening its presence in the diabetes treatment mark...